〇Daiki Tatematsu¹, Shingo Iwami¹ (1. Nagoya University)

〇RUIMING LI¹, Satoru Sugimoto¹, Eiryo Kawakami¹ (1. Institute of Physical and Chemical Research)

〇Eriko Hasumi¹, Chen Yein^1,3, Sumie Miyamoto², Katsuhito Fujiu^1,2 (1. The university of Tokyo Hospital, 2. The university of Tokyo , 3. SIMPLEX QUANTUM co.)

〇Ryouichi Chatani¹, Shotaro Sonoike¹, Mariko Nio¹, Masayuki Kaneko¹, Isao Sano², Hiroki Kato³, Hiroko Otaki⁴, Yoichi Nakamoto³, Kunihiko Kido⁴, Naoki Fukazawa¹ (1. Clinical Development Division, Chugai Pharmaceutical Co., Ltd., 2. Digital Transformation Unit, Chugai Pharmaceutical Co., Ltd., 3. Industrial Digital Business Unit, Hitachi, Ltd., 4. Research & Development Group, Hitachi, Ltd.)

〇Takanori Kawabata^1,2, Kohtaro Fujihashi^3,4,5,6,7, Rika Nakahashi^3,4,5, Tomoyuki Yamanoue^3,4, Machita Tomonori^3,4, Taku tsuzuki^8,4, Tsuyoshi Tatsukawa^8,4, Eiryo Kawakami^1,9,10 (1. Department of Artificial Intelligence Medicine, Graduate School of Medicine, Chiba University, 2. National Cerebral and Cardiovascular Center, 3. Department of Human Vaccinology, Chiba University Hospital, 4. Chiba University Snergy Institute for Futuristic Mucosal Vaccine Research and Development, 5. Division of Infectious Disease Vaccine Research and Development, Research Institute of Disaster Medicine, Chiba University, 6. Division of Mucosal Vaccine, International Vaccine Design Center, Institute of Medical Science,The University of Tokyo, 7. Department of Pediatric Dentistry, School of Dentistry, The University of Alabama at Birmingham, 8. Epistra Inc., 9. Advanced Data Science Project (ADSP), RIKEN Information R&D and Strategy Headquarters, RIKEN, 10. Institute for Advanced Academic Research (IAAR), Chiba University)